ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Survival impact of a KEAP1-NFE2L2 radiomics model in PDL1 ≥ 50% non-small cell lung cancer treated with pembrolizumab: the PEMBROMIC study.

Coline Le Meur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.